Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shree Ganesh Biotech (India) Ltd has submitted a compliance certificate to stock exchanges (BSE, Calcutta SE, Metropolitan Stock Exchange) under SEBI Regulation 74(5) for the quarter ended 31st December 2025. The certificate was issued by the company's Registrar and Share Transfer Agent (RTA), Satellite Corporate Services Pvt Ltd, confirming that physical share certificates received for dematerialization were duly verified, mutilated, cancelled, and the depository recorded as the registered owner. Importantly, the RTA noted that no physical share certificates were received for dematerialization during this quarter. The filing is signed by Director Aman Patel.
This is a routine quarterly regulatory compliance filing with no business or financial impact on shareholders. It simply confirms no physical-to-demat conversion activity occurred during the quarter, indicating low investor preference for paper share certificates.